Elite in Pseudohypoparathyroidism

Giovanna R. Mantovani

R. Maestro Cardim 769, Bela Vista, 
Sao Paulo, SP, BR 
Elite in Pseudohypoparathyroidism
R. Maestro Cardim 769, Bela Vista, 
Sao Paulo, SP, BR 
OverviewLocationsClinical Research

Overview

Giovanna Mantovani practices in Sao Paulo, Brazil. Ms. Mantovani is rated as an Elite expert by MediFind in the treatment of Pseudohypoparathyroidism. Her top areas of expertise are Pseudohypoparathyroidism, Albright's Hereditary Osteodystrophy, Progressive Osseous Heteroplasia, Endoscopic Transnasal Transsphenoidal Surgery, and Hormone Replacement Therapy (HRT).

Her clinical research consists of co-authoring 468 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 47 articles in the study of Pseudohypoparathyroidism.

Gender
Female

Locations

R. Maestro Cardim 769, Bela Vista, Sao Paulo, SP 01323001, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Registry for Patients With Chronic Hypoparathyroidism
PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Registry for Patients With Chronic Hypoparathyroidism
Enrollment Status: Active_not_recruiting
Publish Date: September 29, 2025
Intervention Type: Other
A Randomized, Double-blind, Placebo-controlled, Adaptive Study to Evaluate Symptom Improvement and Metabolic Control Among Adult Subjects With Symptomatic Hypoparathyroidism Treated With Recombinant Human Parathyroid Hormone [rhPTH(1-84)]
A Randomized, Double-blind, Placebo-controlled, Adaptive Study to Evaluate Symptom Improvement and Metabolic Control Among Adult Subjects With Symptomatic Hypoparathyroidism Treated With Recombinant Human Parathyroid Hormone [rhPTH(1-84)]
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Biological
Study Drug: rhPTH(1-84)
Study Phase: Phase 4
View 1 Less Clinical Trial

468 Total Publications

Sequential Treatment for Osteoporosis After Teriparatide: A Real-Life Long-Term Comparison Between Zoledronic Acid and Denosumab.
Sequential Treatment for Osteoporosis After Teriparatide: A Real-Life Long-Term Comparison Between Zoledronic Acid and Denosumab.
Journal: Journal of clinical medicine
Published: July 31, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Mantovani's expertise for a condition
ConditionClose
View All 11 Elite Conditions
View All 21 Distinguished Conditions
View All 26 Advanced Conditions
View All 56 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile